206 related articles for article (PubMed ID: 15586177)
1. Somatic mosaicism for a heterozygous deletion of the survival motor neuron (SMN1) gene.
Eggermann T; Zerres K; Anhuf D; Kotzot D; Fauth C; Rudnik-Schöneborn S
Eur J Hum Genet; 2005 Mar; 13(3):309-13. PubMed ID: 15586177
[TBL] [Abstract][Full Text] [Related]
2. Transmission ratio distortion in the spinal muscular atrophy locus: data from 314 prenatal tests.
Botta A; Tacconelli A; Bagni I; Giardina E; Bonifazi E; Pietropolli A; Clementi M; Novelli G
Neurology; 2005 Nov; 65(10):1631-5. PubMed ID: 16301493
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a highly efficient and reliable carrier-screening test.
Su YN; Hung CC; Li H; Lee CN; Cheng WF; Tsao PN; Chang MC; Yu CL; Hsieh WS; Lin WL; Hsu SM
Hum Mutat; 2005 May; 25(5):460-7. PubMed ID: 15832310
[TBL] [Abstract][Full Text] [Related]
4. Determination of SMN1 and SMN2 copy number using TaqMan technology.
Anhuf D; Eggermann T; Rudnik-Schöneborn S; Zerres K
Hum Mutat; 2003 Jul; 22(1):74-8. PubMed ID: 12815596
[TBL] [Abstract][Full Text] [Related]
5. Genetic testing and risk assessment for spinal muscular atrophy (SMA).
Ogino S; Wilson RB
Hum Genet; 2002 Dec; 111(6):477-500. PubMed ID: 12436240
[TBL] [Abstract][Full Text] [Related]
6. Population screening and cascade testing for carriers of SMA.
Smith M; Calabro V; Chong B; Gardiner N; Cowie S; du Sart D
Eur J Hum Genet; 2007 Jul; 15(7):759-66. PubMed ID: 17392705
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of SMA patients without homozygous SMN1 deletions using a new strategy for identification of SMN1 subtle mutations.
Clermont O; Burlet P; Benit P; Chanterau D; Saugier-Veber P; Munnich A; Cusin V
Hum Mutat; 2004 Nov; 24(5):417-27. PubMed ID: 15459957
[TBL] [Abstract][Full Text] [Related]
8. Prenatal diagnosis for risk of spinal muscular atrophy.
Cuscó I; Barceló MJ; Soler C; Parra J; Baiget M; Tizzano E
BJOG; 2002 Nov; 109(11):1244-9. PubMed ID: 12452462
[TBL] [Abstract][Full Text] [Related]
9. Spinal muscular atrophy diagnostics.
Prior TW
J Child Neurol; 2007 Aug; 22(8):952-6. PubMed ID: 17761649
[TBL] [Abstract][Full Text] [Related]
10. Rapid prenatal diagnosis of spinal muscular atrophy by denaturing high-performance liquid chromatography system.
Shaw SW; Cheng PJ; Chang SD; Lin YT; Hung CC; Chen CP; Su YN
Acta Obstet Gynecol Scand; 2008; 87(9):960-8. PubMed ID: 18720039
[TBL] [Abstract][Full Text] [Related]
11. Duplications and de novo deletions of the SMNt gene demonstrated by fluorescence-based carrier testing for spinal muscular atrophy.
Chen KL; Wang YL; Rennert H; Joshi I; Mills JK; Leonard DG; Wilson RB
Am J Med Genet; 1999 Aug; 85(5):463-9. PubMed ID: 10405443
[TBL] [Abstract][Full Text] [Related]
12. Implementation of SMA carrier testing in genetic laboratories: comparison of two methods for quantifying the SMN1 gene.
Cuscó I; Barceló MJ; Baiget M; Tizzano EF
Hum Mutat; 2002 Dec; 20(6):452-9. PubMed ID: 12442269
[TBL] [Abstract][Full Text] [Related]
13. Neonatal spinal muscular atrophy with multiple contractures, bone fractures, respiratory insufficiency and 5q13 deletion.
García-Cabezas MA; García-Alix A; Martín Y; Gutiérrez M; Hernández C; Rodríguez JI; Morales C
Acta Neuropathol; 2004 May; 107(5):475-8. PubMed ID: 14968368
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
[TBL] [Abstract][Full Text] [Related]
15. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS.
Veldink JH; Kalmijn S; Van der Hout AH; Lemmink HH; Groeneveld GJ; Lummen C; Scheffer H; Wokke JH; Van den Berg LH
Neurology; 2005 Sep; 65(6):820-5. PubMed ID: 16093455
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis and prenatal prediction of spinal muscular atrophy in Chinese patients by the combination of restriction fragment length polymorphism analysis, denaturing high-performance liquid chromatography, and linkage analysis.
Chen WJ; Wu ZY; Lin MT; Su JF; Lin Y; Murong SX; Wang N
Arch Neurol; 2007 Feb; 64(2):225-31. PubMed ID: 17296838
[TBL] [Abstract][Full Text] [Related]
17. [Quantitative analysis of the genes determining spinal muscular atrophy].
Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
[TBL] [Abstract][Full Text] [Related]
18. Prenatal diagnosis of spinal muscular atrophy: Indian scenario.
Kesari A; Rennert H; Leonard DG; Phadke SR; Mittal B
Prenat Diagn; 2005 Aug; 25(8):641-4. PubMed ID: 16049987
[TBL] [Abstract][Full Text] [Related]
19. Genetic risk assessment in carrier testing for spinal muscular atrophy.
Ogino S; Leonard DG; Rennert H; Ewens WJ; Wilson RB
Am J Med Genet; 2002 Jul; 110(4):301-7. PubMed ID: 12116201
[TBL] [Abstract][Full Text] [Related]
20. A new splice site mutation in the SMN1 gene causes discrepant results in SMN1 deletion screening approaches.
Eggermann T; Eggermann K; Elbracht M; Zerres K; Rudnik-Schöneborn S
Neuromuscul Disord; 2008 Feb; 18(2):146-9. PubMed ID: 18155522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
